Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Depreciation & Amortization (CF): 2018-2024

Historic Depreciation & Amortization (CF) for Black Diamond Therapeutics (BDTX) over the last 7 years, with Dec 2024 value amounting to $343,000.

  • Black Diamond Therapeutics' Depreciation & Amortization (CF) rose 720.00% to $123,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $205,000, marking a year-over-year increase of 294.23%. This contributed to the annual value of $343,000 for FY2024, which is 21.51% down from last year.
  • Black Diamond Therapeutics' Depreciation & Amortization (CF) amounted to $343,000 in FY2024, which was down 21.51% from $437,000 recorded in FY2023.
  • Black Diamond Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $508,000 for FY2022, and its period low was $52,000 during FY2020.
  • For the 3-year period, Black Diamond Therapeutics' Depreciation & Amortization (CF) averaged around $429,333, with its median value being $437,000 (2023).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 294.23% in 2021, then fell by 21.51% in 2024.
  • Yearly analysis of 5 years shows Black Diamond Therapeutics' Depreciation & Amortization (CF) stood at $52,000 in 2020, then soared by 294.23% to $205,000 in 2021, then skyrocketed by 147.80% to $508,000 in 2022, then fell by 13.98% to $437,000 in 2023, then decreased by 21.51% to $343,000 in 2024.